BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34180367)

  • 1. Imaging of prostate cancer: optimizing affinity to prostate specific membrane antigen by spacer modifications in a tumor spheroid model.
    Krishnan MA; Pandit A; Sharma R; Chelvam V
    J Biomol Struct Dyn; 2022; 40(20):9909-9930. PubMed ID: 34180367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cell-impermeable luminogenic probe for near-infrared imaging of prostate-specific membrane antigen in prostate cancer microenvironments.
    Yang X; Nao SC; Lin C; Kong L; Wang J; Ko CN; Liu J; Ma DL; Leung CH; Wang W
    Eur J Med Chem; 2023 Nov; 259():115659. PubMed ID: 37499288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A targeted near-infrared nanoprobe for deep-tissue penetration and imaging of prostate cancer.
    Asha Krishnan M; Yadav K; Roach P; Chelvam V
    Biomater Sci; 2021 Mar; 9(6):2295-2312. PubMed ID: 33554988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, radiolabeling and biological evaluation of new urea-based peptides targeting prostate specific membrane antigen.
    Mosayebnia M; Hajimahdi Z; Beiki D; Rezaeianpour M; Hajiramezanali M; Geramifar P; Sabzevari O; Amini M; Hatamabadi D; Shahhosseini S
    Bioorg Chem; 2020 Jun; 99():103743. PubMed ID: 32217372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PSMA-targeted NIR probes for image-guided detection of prostate cancer.
    Cilibrizzi A; Wang JT; Memdouh S; Iacovone A; McElroy K; Jaffar N; Young JD; Hider RC; Blower P; Al-Jamal K; Abbate V
    Colloids Surf B Biointerfaces; 2022 Oct; 218():112734. PubMed ID: 35952398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spacer length effects on in vitro imaging and surface accessibility of fluorescent inhibitors of prostate specific membrane antigen.
    Liu T; Nedrow-Byers JR; Hopkins MR; Berkman CE
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7013-6. PubMed ID: 22018464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A high-affinity [(18)F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer.
    Ganguly T; Dannoon S; Hopkins MR; Murphy S; Cahaya H; Blecha JE; Jivan S; Drake CR; Barinka C; Jones EF; VanBrocklin HF; Berkman CE
    Nucl Med Biol; 2015 Oct; 42(10):780-7. PubMed ID: 26169882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer.
    Chatalic KL; Veldhoven-Zweistra J; Bolkestein M; Hoeben S; Koning GA; Boerman OC; de Jong M; van Weerden WM
    J Nucl Med; 2015 Jul; 56(7):1094-9. PubMed ID: 25977460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer.
    Harada N; Kimura H; Onoe S; Watanabe H; Matsuoka D; Arimitsu K; Ono M; Saji H
    J Nucl Med; 2016 Dec; 57(12):1978-1984. PubMed ID: 27417647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer.
    Benešová M; Schäfer M; Bauder-Wüst U; Afshar-Oromieh A; Kratochwil C; Mier W; Haberkorn U; Kopka K; Eder M
    J Nucl Med; 2015 Jun; 56(6):914-20. PubMed ID: 25883127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Linker Modification on Tumor-to-Kidney Contrast of
    Kuo HT; Pan J; Zhang Z; Lau J; Merkens H; Zhang C; Colpo N; Lin KS; Bénard F
    Mol Pharm; 2018 Aug; 15(8):3502-3511. PubMed ID: 29920108
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and biological evaluation of copper-64 radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN(7-14)NH2], a novel bivalent targeting vector having affinity for two distinct biomarkers (GRPr/PSMA) of prostate cancer.
    Bandari RP; Jiang Z; Reynolds TS; Bernskoetter NE; Szczodroski AF; Bassuner KJ; Kirkpatrick DL; Rold TL; Sieckman GL; Hoffman TJ; Connors JP; Smith CJ
    Nucl Med Biol; 2014 Apr; 41(4):355-63. PubMed ID: 24508213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of peptide-based imaging agents [
    Zhang-Yin J; Provost C; Cancel-Tassin G; Rusu T; Penent M; Radulescu C; Comperat E; Cussenot O; Montravers F; Renard-Penna R; Talbot JN; Prignon A
    Nucl Med Biol; 2020; 84-85():88-95. PubMed ID: 32251995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro and In Vivo Evaluation of Targeted Fluorescent Imaging Agents for Diagnosis and Resection of Cancer.
    Yadav K; Krishnan MA; Chelvam V
    Curr Protoc; 2022 Dec; 2(12):e623. PubMed ID: 36571584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Series of PSMA-Targeted Near-Infrared Fluorescent Imaging Agents.
    Chen Y; Minn I; Rowe SP; Lisok A; Chatterjee S; Brummet M; Banerjee SR; Mease RC; Pomper MG
    Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of prostate-specific membrane antigen ligands in clinical translation research for diagnosis of prostate cancer.
    Sengupta S; Asha Krishnan M; Chattopadhyay S; Chelvam V
    Cancer Rep (Hoboken); 2019 Aug; 2(4):e1169. PubMed ID: 32721116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of a multifunctional probe with a high affinity for prostate-specific membrane antigen (PSMA) and bone.
    Hirata S; Mishiro K; Higashi T; Fuchigami T; Munekane M; Arano Y; Kinuya S; Ogawa K
    Nucl Med Biol; 2022; 114-115():34-41. PubMed ID: 36088875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and pre-clinical evaluation of a new class of high-affinity
    Kelly J; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Ponnala S; Babich JW
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):647-661. PubMed ID: 27847991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-Target Binding Ligands with Modulated Pharmacokinetics for Endoradiotherapy of Prostate Cancer.
    Kelly JM; Amor-Coarasa A; Nikolopoulou A; Wüstemann T; Barelli P; Kim D; Williams C; Zheng X; Bi C; Hu B; Warren JD; Hage DS; DiMagno SG; Babich JW
    J Nucl Med; 2017 Sep; 58(9):1442-1449. PubMed ID: 28450562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.